- AU$104.88bn
- AU$122.66bn
- $15.56bn
- 98
- 35
- 13
- 48
Annual income statement for Csl, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10,310 | 10,562 | 13,310 | 14,800 | 15,558 |
| Cost of Revenue | |||||
| Gross Profit | 5,843 | 5,732 | 6,825 | 7,671 | 8,079 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 7,180 | 7,635 | 10,241 | 10,988 | 11,424 |
| Operating Profit | 3,130 | 2,927 | 3,069 | 3,812 | 4,134 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 2,963 | 2,780 | 2,663 | 3,375 | 3,724 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 2,375 | 2,255 | 2,244 | 2,714 | 3,136 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 2,375 | 2,255 | 2,194 | 2,642 | 3,002 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 2,375 | 2,255 | 2,194 | 2,642 | 3,002 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.37 | 5.03 | 4.53 | 5.45 | 6.12 |
| Dividends per Share |